ロード中...
Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19
The novel human coronavirus-2 (HCoV-2), called SARS-CoV-2, is the causative agent of Coronavirus Induced Disease (COVID-19) and has spread causing a global pandemic. Currently, there is no vaccine to prevent infection nor any approved drug for the treatment. The development of a new drug is time-con...
保存先:
| 出版年: | Chem Biol Interact |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7536130/ https://ncbi.nlm.nih.gov/pubmed/33031791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cbi.2020.109282 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|